Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
First wave of new molecular entities has potential to generate 14 approvals
BeiGene bags FDA approval for first product Brukinsa in lymphoma
Also the first approval for a Chinese-developed cancer drug in US
Amarin wins FDA advisory nod for Vascepa cardiovascular expansion
Approval likely for fish-oil derived drug following speedy review
Shionogi scores FDA approval for new cUTI antibiotic
Pivotal new treatment for adults with complicated urinary tract infection
Articles
-
Strengthening business competition and reducing anti-competitive practicesHow the CMA is tackling high prices for essential drugs
-
The end of pharmaSome parts of our industry may go the way of the kitchen display cabinet and the word processor
-
We’ll need more than a spoonful of sugar to counter vaccine hesitancyBy Satinder Phull
-
The long and winding road to asthma breakthroughsRespiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks
-
Patient journey mapping: exploring the clinical and the emotional journeyBy Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew
Pharmaceutical Market Europe - November 2019
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
Increased discount leads NICE to reverse positon on Clovis cancer drug
Ovarian cancer drug Rubraca now recommended for use within the Cancer Drugs Fund
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
The end of pharma
Some parts of our industry may go the way of the kitchen display cabinet and the word processor
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
-
Account Executive
-
Salary TBC
-
Account Director
-
Salary TBC
-
Account Supervisor
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
- Genital herpes vaccine candidate heads for human studies
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- FDA advisors say no to empagliflozin in type 1 diabetes
- Novartis makes case for NASH candidate tropifexor
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- AbbVie sells $30bn of bonds ahead of Allergan merger
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- BeiGene bags FDA approval for first product Brukinsa in lymphoma
- Amarin wins FDA advisory nod for Vascepa cardiovascular expansion
- Shionogi scores FDA approval for new cUTI antibiotic
- Merck acquires pre-clinical biotech Calporta for up to $576m
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
- Pharmaceutical innovation in the APAC region
- A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Quick links
Infographics
